Subject: Reminder: Reporting of Mpox data to ECDC November 5th
From: "Lina Nerlander" <[email-masked]>
To: "Alexandra Mailles" <[email-masked]>, "Alise Vindiga" <[email-masked]>, "Amaryl Lecompte" <[email-masked]>, "Amina Vujic" <[email-masked]>, "Ana Mendes" <[email-masked]>, "Andreas Reich" <[email-masked]>, "Angeline McIntyre" <[email-masked]>, "Anna Margret Gudmundsdottir" <[email-masked]>, "Anthony Ortiz" <[email-masked]>, "Anthony Ortiz" <[email-masked]>, "Aoife Colgan" <[email-masked]>, "Aoife Colgan" <[email-masked]>,Astrid Louise Løvlie <Astrid.
Cc: "Mateusz Markowicz" <[email-masked]>, "Stephan Aberle" <[email-masked]>,Lena König <[email-masked]>, "Ziad El-Khatib" <[email-masked]>, "Tinne Lernout" <[email-masked]>, "Javiera Rebolledo" <[email-masked]>, "Dominique Van Beckhoven" <[email-masked]>, "Jessika Deblonde" <[email-masked]>, "Elitsa Panayotova" <[email-masked]>, "Iva Trifonova" <[email-masked]>, "Ognyan Mikov" <[email-masked]>, "Iva Christova" <[email-masked]>, "Ivailo Ale
Date: Wed, 29 Oct 2025 12:35:33 +0200

Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu 
saatja korral palume linke ja faile mitte avada.

To:        Operational Contact Points mpox

CC:      National Focal points for Emerging and Vector Borne Diseases

              National Focal points for HIV/AIDS, STIs and hepatitis B/C

               National Focal points for Surveillance

               National Coordinators

Dear Colleagues,

This is a reminder that the deadline for the next reporting of mpox cases is 
November 5th. As always please report to TESSy through the EpiPulse portal 
<https://epipulse.ecdc.europa.eu/tessywebapp/Upload/Upload.aspx> .

If you have Clade I cases, please report these as soon as possible in 
EpiPulse Events so that we become aware of them as soon as possible, and 
then to follow up with Tessy reporting.

We are very interested in getting as complete data as possible on all cases 
in tessy – especially Clade I but also Clade II to use as comparison as we 
try to understand more about severity, breakthrough infections etc. Please 
add as much information as you can in Tessy on prior vaccination, prior 
infection, HIV status, transmission category, clade, travel history, 
symptoms, hospitalisation, severity and outcome. It is ok to add information 
later as it becomes available so it is better to report soon and 
complete/update the record later.

Please find the link to the threat assessment brief published last week: 
<https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-detection-autochthonous-transmission-monkeypox-virus> 
Threat Assessment Brief: Detection of autochthonous transmission of 
monkeypox virus clade Ib in the EU/EEA

Thank you very much for all your hard work. If you have any questions or 
need further information, please don't hesitate to contact us at 
[email-masked] <mailto:[email-masked]>  (ECDC) or 
<mailto:[email-masked]> [email-masked] (WHO Europe).

Kind regards,

Lina Nerlander

On behalf of ECDC and WHO EURO mpox teams

Lina Nerlander

BMBCh, MPH, PhD

Principal Expert Sexually Transmitted Infections

STI, Blood‑borne Viruses and TB

,

DVD

Phone +46 (0)8 58 60  <tel:1080> 1080

 <mailto:[email-masked]> [email-masked]

European Centre for
Disease Prevention and Control (ECDC)

Gustav III:s boulevard 40, 169 73 Solna, Sweden

Phone +46 (0)8 58 60 10 00

www.ecdc.europa.eu

Follow ECDC on:

Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly 
requested, to, consecutively, refrain from disclosing its content to any 
third party, delete it and inform its sender of the erroneous transmittal.

Classified as ECDC NORMAL